Abstract
Among various genomic features in the blood, methylation pattern could be useful not only in determining whether cancer is present, but in revealing its origin. The purposes of this prospective study were to evaluate the diagnostic performance of methylation sensitive restriction enzyme digestion followed by sequencing method (MRE-seq) using cell-free DNA (cfDNA) in the diagnosis of cancer and to investigate tissue-of-origin (TOO) using deep neural network (DNN).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
